Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment-Reference-Cited by-同舟云学术

Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment

Published:2006-05-19 Issue:3 Volume:1 Page:123-129
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Martinelli Erika,Troiani Teresa,Morgillo Floriana,Piccirillo Maria Carmela,Monaco Katia,Morelli Maria Pia,Cascone Tina,Ciardiello Fortunato

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11523-006-0022-5.pdf

Reference41 articles.

1. Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19:6550–6565

2. Woodburn JR (1999) The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82:241–250

3. Yarden Y (2001) The EGFR family and its ligands in human cancer signaling mechanisms and therapeutic opportunities. Eur J Cancer 37:S3–S8

4. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137

5. Ciardiello F, Tortora G (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958–2970

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and in vitro antitumor activity of 6-aryloxyl substituted quinazolinederivatives;Turkish Journal of Chemistry;2022-01-01

2. Synthesis of phenyl (6-(2-fluoro-4-nitrophenoxy)pyrimidin-4-yl)carbamate;3RD INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2020);2021

3. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors;European Journal of Medicinal Chemistry;2018-06

4. Application of nano-surface and molecular-orientation limited proteolysis to LC–MS bioanalysis of cetuximab;Bioanalysis;2016-05

5. Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4;Bioorganic & Medicinal Chemistry Letters;2009-12